Business Context and Reporting Period
This Form 6-K filing by Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) is dated November 17, 2021. The report primarily announces a proposed private offering of $140 million in principal amount of convertible senior notes to qualified institutional buyers under Rule 144A. The filing also references unaudited financial statements for the nine months ended September 30, 2021, and September 30, 2020, which are provided as exhibits rather than detailed within the text of this specific form.
Key Financial Metrics
The text of this Form 6-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.2 for financial statements and Exhibit 99.3 for the Operating and Financial Review). The only specific financial figure disclosed in the main text is the proposed $140 million principal amount for the new convertible senior notes offering.
Material Changes
The primary material change disclosed is the initiation of the $140 million convertible senior notes offering. Additionally, the filing notes that a preliminary offering memorandum (Exhibit 99.4) contains updated risk factor disclosures that supplement or update prior company disclosures.
Guidance, Outlook, and Risks
Management commentary, specific guidance, and detailed outlook are located in the attached "Operating and Financial Review and Prospects" (Exhibit 99.3) and are not summarized in the body of this filing. The filing explicitly states that the preliminary offering memorandum includes updated risk factor disclosures. The information in this Form 6-K is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Verify the final terms and closing status of the proposed $140 million convertible senior notes offering.
- Review Exhibit 99.2 for the actual unaudited financial results for the nine months ended September 30, 2021.
- Examine Exhibit 99.4 for the specific updated risk factors disclosed to prospective investors.
- Consult Exhibit 99.3 for the full Operating and Financial Review and Prospects to assess management's outlook.